CD4 and primary cutaneous T-cell non-Hodgkin lymphoma: For normal T cells, we used activated PBMCs from healthy human donors and isolated CD4+ cells by immunomagnetic separation, as CD4+ is the dominant immunophenotype of CTCL [34,35] (Figure 1A).